Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Breast Neoplasms, Male (Phase 1/Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Colorectal Neoplasms (Phase 2)
Diabetes Mellitus (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Kidney Neoplasms (Phase 2)
Liver Neoplasms (Phase 1)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 2)
Melanoma (Phase 2)
Mouth Neoplasms (Phase 1/Phase 2)
Neoplasm Metastasis (Phase 4)
Neoplasms (Phase 4)
Oropharyngeal Neoplasms (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Pleural Effusion, Malignant (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Thyroid Neoplasms (Phase 4)
Tongue Neoplasms (Phase 1/Phase 2)
Urinary Bladder Neoplasms (Phase 1)
Uterine Cervical Neoplasms (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
